Correction to: Combination treatment with an antibody-drug conjugate (A1mcMMAF) targeting the oncofetal glycoprotein 5T4 and carboplatin improves survival in a xenograft model of ovarian cancer
Name:
Wan2019_Article_CorrectionToCo ...
Size:
360.9Kb
Format:
PDF
Description:
Full text, Open Access article
Affiliation
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, 5th Floor Research, St Mary's Hospital, Oxford Road, Manchester, M13 9WL, UKIssue Date
2019
Metadata
Show full item recordCitation
Wan YL, Sapra P, Bolton J, Chua JX, Durrant LG, Stern PL. Correction to: Combination treatment with an antibody-drug conjugate (A1mcMMAF) targeting the oncofetal glycoprotein 5T4 and carboplatin improves survival in a xenograft model of ovarian cancer. Target Oncol. 2019.Journal
Targeted OncologyDOI
10.1007/s11523-019-00677-xPubMed ID
31583515Additional Links
https://dx.doi.org/10.1007/s11523-019-00677-xType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1007/s11523-019-00677-x
Scopus Count
Collections
Related articles
- Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer.
- Authors: Wan YL, Sapra P, Bolton J, Chua JX, Durrant LG, Stern PL
- Issue date: 2019 Aug
- Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia.
- Authors: McGinn OJ, Krishnan S, Bourquin JP, Sapra P, Dempsey C, Saha V, Stern PL
- Issue date: 2017 Jun
- A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models.
- Authors: Wang R, Lai Q, Tang L, Tao Y, Yao Y, Liu Y, Lu Y, Shen C, Lu R, Fan C, Zhang R, Wang Y, Yu L, Yang T, Wu Y, Peng Y, Wei X, Fu Y, Lai W, Gou L, Yang J
- Issue date: 2018
- 5T4 oncofetal antigen expression in ovarian carcinoma.
- Authors: Wrigley E, McGown AT, Rennison J, Swindell R, Crowther D, Starzynska T, Stern PL
- Issue date: 1995 Jul
- The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin.
- Authors: Boghaert ER, Sridharan L, Khandke KM, Armellino D, Ryan MG, Myers K, Harrop R, Kunz A, Hamann PR, Marquette K, Dougher M, DiJoseph JF, Damle NK
- Issue date: 2008 Jan